Cardiovascular Medicine and Prevention Update for Primary Care Virtual Symposium 2022

April 8, 2022

Practice Gaps and Needs

Cardiovascular medicine is a vast area of clinical practice with continually evolving and developing research, guidelines, best practices, and new medications and technology. Primary care providers are challenged to optimally manage a multitude of diseases involving the cardiovascular system including the failing heart, the heart with abnormal arrhythmias and the circulation affected by abnormal cholesterol metabolism and hypertension. National guidelines helping clinicians establish best practices are refined annually. Implications of new guidelines, new medications and their utilization will be discussed in addition to a review of best practices on several topics commonly seen by primary care providers.

The implications of ambulatory monitor test results in symptomatic patients will be addressed. We will focus on updated measures including management of hypertension in the elderly, management of side effects of statins and the use of integrative techniques for patients with cardiovascular disease. Several new drugs that might improve outcomes for patients with heart failure will be presented and put into perspective for all types of heart failure. Difficult issues surrounding when to stop treating severe end stage heart failure will be discussed. Tips on appropriate use of anticoagulation will also be presented.

Accurate diagnosis and treatment of cardiac causes of syncope and postural hypotension are a common problem for primary care physicians and advanced practice providers. Updated treatment information will be discussed. Breakout sessions will provide focused discussion on common problems such as interpreting incidental findings from coronary CT scans, preoperative assessment for cardiac risk, and medication adherence for chronic therapy. Additionally, we will address the role of closure devices for stroke prevention and update clinicians on long term cardiac effects of COVID.

Target Audience

This activity is planned by and designed for physicians, nurse practitioners, physician assistants, pharmacists, nurses and other allied health personnel working in the field of primary care who treat and evaluate patients in need of prevention and treatment of cardiovascular diseases.

Elements of Competence

This CE activity has been designed to improve learner competence and focuses on the American Board of Medical Specialties' areas of patient care and procedural skills, medical knowledge, and interprofessional and communication skills.

This activity focuses on the Interprofessional competencies of roles/responsibilities, interprofessional communication, and teams/teamwork.

This activity also focuses on the Center for Advancement of Pharmacy Education (CAPE) competency of interprofessional collaboration.

Learning Objectives

At the conclusion of the activity, the healthcare team will be able to:

  1. Identify best practices for the treatment of hypertension in the elderly and best practices for medication adherence and best practices for dealing with side effects of statins.
  2. Discuss implications of incidental findings on CT scans
  3. Assess the implications of new treatments for heart failure.
  4. Summarize best practices for stroke prevention including anticoagulation and device placement.
  5. Outline new and evolving information on the role of SGLT2 inhibitors for heart failure.
  6. Discuss implications of symptoms of palpitations and hypotension.
  7. Examine current and evolving data and research pertaining to COVID in cardiovascular medicine.
  8. Outline best practices for use of palliative care and evaluation of cardiac risk prior to non-cardiac surgery.
  9. Define the role of integrative medicine in patients with heart disease.
Course summary
Available credit: 
  • 6.75 AAPA Category 1 CME
  • 4.75 MOC: ABIM Medical Knowledge Points (Part II)
  • 6.75 ACPE Contact Hours - Pharmacist
  • 6.75 AMA PRA Category 1 Credit
    • 6.75 AAFP Credits
  • 6.75 ANCC Contact Hours
    • 2.75 ANCC Pharmacotherapy Contact Hours
  • 6.75 CDR CPEUs
  • 6.75 University of Wisconsin–Madison Continuing Education Hours
    • 6.75 Approved for AMA PRA Category 1 Credit™
Registration opens: 
01/22/2022
Course expires: 
05/15/2022
Event starts: 
04/08/2022 - 7:50am CDT
Event ends: 
04/08/2022 - 5:00pm CDT
Cost:
$150.00
Rating: 
4

Friday, April 8, 2022

All times listed are in Central Daylight Time (CDT) 

7:55 AMWelcome & Introduction
8:00 AM

Session I: Prevention

Moderator: Matthew Tattersall, DO, MS

8:05 AM

8:30 AM

8:55 AM

9:20 AM

 Under Pressure? Over Pressure? No Pressure! Controlling Blood Pressure in Older Patients. (Adam Gepner, MD)

 Integrative Medicine Cardiovascular Pearls (David Rakel, MD)

 Statins: When Muscles Aches are Head Aches (Jim Stein, MD)

 Panel Discussion

9:50 AMBreak & Exhibits 
10:00 AM

Session II: Heart Failure 

Moderator: Aurangzeb Baber, MD

10:05 AM

10:30 AM

10:55 AM

11:20 AM

 HF Preserved EF, SGLT2, and Indications for Specialized Imaging (David Pham, MD)

 HF Reduced EF: New Kids on the Block (Ravi Dhingra, MD, MPH)

 Case Studies: Palliative Care (Liana Eskola, DO)

 Panel Discussion

11:50 AMIntro to Breakouts 
12:00 PM

Lunch

Exhibit Hall Open for Drop-In Sessions

Session III: Breakouts 

Learners select 3 for the following

  • Management of Incidental Findings of Coronary Artery Calcifications (Rod Deaño, MD, MPH)
  • Adherence: Barriers and Enablers to Taking Medication (Karen Kopacek, MS, RPh)
  • Stroke Prevention: An Update on Interventional Procedures for LAA and PFO Closure (Kurt Jacobson, MD)
  • Non-Cardiac Surgery in Patients with Heart Disease: The Preoperative Evaluation in 2022 (Kathy Wackerle, APNP)
  • COVID 19: Long Term Cardiovascular Outcomes (Brad Ternus, MD)
  • Optimizing Heart Failure Treatment (Joan Hermsen, DNP, APNP)
1:00 PMBreakout 1 (Selected at registration)
1:30 PMBreak/Switch to next Breakout
1:40 PMBreakout 2 (Selected at registration)
2:10 PMBreak/Switch to next Breakout
2:20 PMBreakout 3 (Selected at registration)
2:50 PMBreak & Exhibits
3:00 PM

Session IV: Electrophysiology & Intervention

Moderators: Zachary Goldberger, MD, MS & Blake Fleeman, MD

3:05 PM

3:30 PM

3:55 PM

4:20 PM

 Review of Ambulatory Monitors (Craig January, MD, PhD)

 Pearls and Pitfalls of Anticoagulation (Amanda Breuer, PA-C)

 Syncope and POTS (Kathleen Walsh, DO)

 Panel Discussion      

4:50 PMClosing Remarks/Summary
5:00 PMAdjourn

 

This is a virtual conference (central time). Please see the Program for further information.

A link will be sent to participants prior to the activity start date.

COURSE DIRECTORS

*Peter Rahko, MD, Professor of Medicine, Cardiovascular Medicine Division, UW SMPH; Director, Adult Echocardiography Laboratory

*Zachary Goldberger, MD, Associate Professor of Medicine (CHS), Cardiovascular Medicine Division, UW SMPH

PRESENTERS, MODERATORS & PLANNERS

Aurangzeb Baber, MD, Assistant Clinical Professor of Medicine, Cardiovascular Medicine Division, UW SMPH

*Ashley Bartlett, BS, Administrative Program Specialist, Cardiovascular Medicine Division, UW SMPH

*Mark Beamsley, MD, Clinical Associate Professor of Medicine, Department of Family Medicine and Community Health, UW SMPH

*Amanda Breuer, PA-C, Electrophysiology Advanced Practice Provider Team Lead, Cardiovascular Medicine Division, UW SMPH

Rod Deaño, MD, MPH, Assistant Clinical Professor of Medicine, Cardiovascular Medicine Division, UW SMPH

Ravi Dhingra, MD, MPH, Associate Professor of Medicine (CHS), Medical Director of the UW Advanced Heart Disease, Mechanical Support and Transplant Cardiology Program, UW SMPH

Liana Eskola, DO, Assistant Clinical Professor of Medicine, Hematology/Oncology Division, UW SMPH

Blake Fleeman, MD, Assistant Clinical Professor of Medicine, Cardiovascular Medicine Division, UW SMPH

*Adam Gepner, MD, Cardiologist, William S. Middleton Memorial Veterans Hospital; Clinical Adjunct Assistant Professor of Medicine, Cardiovascular Medicine Division, UW SMPH

*Todd Goldman, MD, Clinical Assistant Professor of Medicine, Cardiovascular Medicine Division, UW SMPH; Director of Adult Echocardiography, William S. Middleton Memorial Veterans Hospital

*Joan Hermsen, DNP, APNP, Heart Failure & Transplant Cardiology, APP Supervisor, Cardiovascular Medicine Division, UW SMPH

*Kurt Jacobson, MD, Associate Professor of Medicine (CHS), UW Interventional Cardiology Fellowship Program Director, Cardiovascular Medicine Division, UW SMPH

*Craig January, MD, PhD, Professor of Medicine, Cardiovascular Medicine Division, UW SMPH; Director, Heart Station

*Maryl Johnson, MD, Professor of Medicine (CHS), Heart Failure and Transplant Cardiology, Cardiovascular Medicine Division, UW SMPH

*Karen Kopacek, MS, RPh, Associate Professor (CHS), Associate Dean for Student Affairs, UW-Madison School of Pharmacy

David Pham, MD, Assistant Clinical Professor of Medicine, Cardiovascular Medicine Division, UW SMPH

Kavita Poddar, PhD, RD, CD, Clinical Nutritionist, UWHC

David Rakel, MD, Professor and Chair of Department of Family Medicine and Community Health, UW SMPH

*Sara Scott, BSc, Accreditation Specialist, Office of Continuing Professional Development in Medicine and Public Health, UW SMPH

James Stein, MD, Robert Turell Professor in Cardiovascular Research, Cardiovascular Medicine Division, UW SMPH; Director, Preventive Cardiology Program and Advanced Hypertension Program

*Chuck Stone, MD, Associate Professor of Medicine and Radiology, Cardiovascular Medicine Division, UW SMPH; Director, UW Health Nuclear Cardiology; Director, UW Health Regional Services

*Matthew Tattersall, DO, MS, Assistant Professor of Medicine (CHS), Cardiovascular Medicine Division, UW SMPH

Brad Ternus, MD, Clinical Assistant Professor of Medicine, Cardiovascular Medicine Division, UW SMPH

Kathy Wackerle, APNP, Inpatient Consult Service Advanced Practice Provider, Cardiovascular Medicine Division, UW SMPH

*Kathleen Walsh, DO, Clinical Associate Professor of Medicine, Cardiovascular Medicine and Geriatrics Divisions, UW SMPH; Associate Director, UW Faint and Fall Clinic

*= Planning Committee Member

 

POLICY ON DISCLOSURE

It is the policy of the University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP) to identify, mitigate and disclose all relevant financial relationships with ineligible companies* held by the  speakers/presenters, authors, planners, and other persons who may influence content of this accredited continuing education (CE).  In addition, speakers, presenters and authors must disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation.

For this accredited continuing education activity all relevant financial relationships have been mitigated and detailed disclosures are listed below.

Name

Role

Discussion of Unlabeled/Unapproved uses of drugs/devices in presentation?

Discussion of Unlabeled/Unapproved uses of drugs/devices in presentation?

*Peter Rahko, MD

Planner

Cytokinetics Inc. (Independent Contractor - Consultant),

Merck (Grant / Contract),

Amgen (Grant / Contract)

No

*Zachary Goldberger, MD,

Course Director,

Medical Director

No relevant relationships with ineligible companies to disclose

No

Aurangzeb Baber, MD

Speaker

No relevant relationships with ineligible companies to disclose

No

Ashley Bartlett, BS

Planner

No relevant relationships with ineligible companies to disclose

No

Mark Beamsley, MD

Planner

No relevant relationships with ineligible companies to disclose

No

Amanda Breuer, PA-C

Planner

No relevant relationships with ineligible companies to disclose

No

Rod Deano, MD, MPH

Speaker/Author

No relevant relationships with ineligible companies to disclose

No

Ravi Dhingra, MD, MPH

Speaker/Author

Caredx (Independent Contractor - Consultant),

Bristol Myers Squibb Company (Independent Contractor - Consultant)

Yes

Liana Eskola, DO

Speaker/Author

No relevant relationships with ineligible companies to disclose

No

Blake Fleeman, MD

Speaker/Author

No relevant relationships with ineligible companies to disclose

No

Adam Gepner, MD

Planner, Speaker/Author

U.S. Department of Veterans Affairs (Grant / Contract),

Beam Health Care & Telehealth (Independent Contractor - Other)

No

Todd Goldman, MD

Planner

No relevant relationships with ineligible companies to disclose

No

Joan Hermsen, DNP, APNP

Planner, Speaker/Author

No relevant relationships with ineligible companies to disclose

No

Kurt Jacobson, MD

Planner, Speaker/Author

No relevant relationships with ineligible companies to disclose

No

Craig January, MD, PhD

Planner, Speaker/Author

No relevant relationships with ineligible companies to disclose

No

Maryl Johnson, MD

Planner

Medtronic (Independent Contractor - Data And Safety Monitoring),

NHLBI (Independent Contractor - Data And Safety Monitoring),

CVS (Independent Contractor - Consultant),

Duke Clinical Research Institute (Independent Contractor - Data And Safety Monitoring),

American Board of Internal Medicine (Independent Contractor - Consultant)

No

Karen Kopacek, MS, RPh

Planner, Speaker/Author

No relevant relationships with ineligible companies to disclose

No

David Pham, MD

Speaker/Author

No relevant relationships with ineligible companies to disclose

No

Kavita Poddar, PhD, RD, CD

Planner

No relevant relationships with ineligible companies to disclose

No

David Rakel, MD

Speaker/Author

No relevant relationships with ineligible companies to disclose

No

Sara Scott, BSc

Accreditation Specialist

No relevant relationships with ineligible companies to disclose

No

James Stein, MD

Speaker/Author

Silence Therapeutics (Independent Contractor - Data And Safety Monitoring),

Eli Lilly and Company (Independent Contractor - Data And Safety Monitoring)

No

Chuck Stone, MD

Planner, Speaker/Author

No relevant relationships with ineligible companies to disclose

No

Matthew Tattersall, DO, MS

Planner

No relevant relationships with ineligible companies to disclose

No

Brad Ternus, MD

Speaker

No relevant relationships with ineligible companies to disclose

No

Kathy Wackerle, APNP

Speaker

No relevant relationships with ineligible companies to disclose

No

Kathleen Walsh, DO

Planner, Speaker/Author

No relevant relationships with ineligible companies to disclose

No

*Ineligible companies are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on, patients. The ACCME does not consider providers of clinical services directly to patients to be ineligible entities.

 

Discloser List CME Internal Report

Accreditation Statement

Jointly Accredited Provider Logo

In support of improving patient care, the University of Wisconsin–Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.


Credit Designation Statements

American Medical Association (AMA)

The University of Wisconsin–Madison ICEP designates this virtual live activity for a maximum of 6.75 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

American Nurses Credentialing Center (ANCC)

The University of Wisconsin–Madison ICEP designates this virtual live activity for a maximum of 6.75 ANCC contact hours. 2.75 of which are eligible for pharmacotherapeutic contact hours. 

Accreditation Council for Pharmacy Education (ACPE)

The University of Wisconsin–Madison ICEP designates this virtual live, knowledge-based activity for a maximum of 6.75 hours/6.75 units of CPE credit. Credit can be earned by documenting attendance. Credit will be provided to NABP CPE Monitor within 60 days after the activity completion.

Universal Activity Number (UAN):  JA0000358-0000-22-069-L01-P

American Academy of Physician Assistants (AAPA)

The University of Wisconsin–Madison ICEP has been authorized by the American Academy of PAs  (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 6.75 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

American Academy of Family Physicians (AAFP)

The AAFP has reviewed Cardiovascular Medicine and Prevention Update for Primary Care and deemed it acceptable for up to 6.75 Online Only, Live AAFP Prescribed credit. Term of Approval is from 04/8/2022 to 04/8/2022. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Academy of Nutrition and Dietetics

This activity has been approved by the Commission on Dietetic Registration for 6.75 CPEUs.

American Board of Internal Medicine MOC Credit

American Board of Internal Medicine: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 4.75 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Continuing Education Units (CEUs)

The University of Wisconsin–Madison ICEP, as a member of the University Professional & Continuing Education Association (UPCEA), authorizes this program for 0.675 CEUs or 6.75 hours.

 

 

Available Credit

  • 6.75 AAPA Category 1 CME
  • 4.75 MOC: ABIM Medical Knowledge Points (Part II)
  • 6.75 ACPE Contact Hours - Pharmacist
  • 6.75 AMA PRA Category 1 Credit
    • 6.75 AAFP Credits
  • 6.75 ANCC Contact Hours
    • 2.75 ANCC Pharmacotherapy Contact Hours
  • 6.75 CDR CPEUs
  • 6.75 University of Wisconsin–Madison Continuing Education Hours
    • 6.75 Approved for AMA PRA Category 1 Credit™

Check back periodically for an up-to-date list of exhibitors.

Exhibitor Drop-In: April 8, 2022 12:00 pm - 1:00 pm (CDT)
 

Exhibitors

GE Healthcare

Pfizer, Cardiac Rare Disease

Pfizer, Cardiovascular Metabolic Health

Janssen Pharmaceuticals

Bayer Pharmaceuticals

Merck & Co., Inc.

Boston Scientific

 

Price

Cost:
$150.00
Please login or register to take this course.

REGISTRATION DEADLINE: April 1, 2022
 

CANCELLATION AND REFUND POLICY

Requests for cancellation must be submitted in writing to help@icep.wisc.edu. Cancellation requests received at least 96 hours (April 4, 2022) prior to the conference will allow a full refund except for the $25 nonrefundable processing fee. No refunds will be made for cancellations received less than 96 hours prior to the activity start date.

QUESTIONS ABOUT REGISTRATION

Email help@icep.wisc.edu

PROGRAM CHANGES

Emergency situations occasionally occur and may necessitate topic or speaker changes. The University of Wisconsin–Madison ICEP reserves the right to alter or substitute a topic or speaker without prior notification.

CONFERENCE MATERIALS

Conference materials will be posted on Wednesday, April 6, 2022

ACCESSIBILITY

The University of Wisconsin provides equal opportunities in employment and programming, including Title IX requirements. The University of Wisconsin fully complies with the legal requirements of the ADA and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please notify us at help@icep.wisc.edu

FOR FURTHER INFORMATION

For conference information or details regarding exhibit booths please contact Ashley Bartlett at abartlett@medicine.wisc.edu

Required Hardware/software

Computer, tablet, or smartphone with audio sharing capabilities.